CENTRAL ACTION MUSCLE RELAXANTS - BOTULINUM TOXIN
About This Opportunity
TranslatedThis tender pertains to the procurement of central action muscle relaxants, specifically focusing on botulinum toxin. The objective is to acquire high-quality pharmaceutical products that meet the regulatory standards for medical use. Key requirements include compliance with safety and efficacy guidelines established by health authorities, as well as the provision of detailed documentation regarding the manufacturing process and quality control measures. Suppliers must demonstrate their capability to deliver the products within specified timeframes and ensure proper storage and handling conditions during transportation. The tender is aimed at healthcare institutions seeking to enhance their treatment options for patients with conditions requiring muscle relaxation. It is essential for bidders to provide evidence of previous experience in supplying similar products to healthcare facilities, along with references from past clients. The location for delivery will be specified in the tender documents, and interested parties are encouraged to review all terms and conditions carefully before submitting their proposals. This procurement is crucial for improving patient care and treatment outcomes in various medical settings.
This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors, with a focus on Pharmaceuticals and Security Services. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 142,614.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender concerns the procurement of central muscle relaxants, specifically botulinum toxin, intended for medical use within Portugal. The contracting authority is expected to adhere to national regulations governing pharmaceutical procurement, ensuring compliance with both safety and efficacy standards. Botulinum toxin, widely recognized for its therapeutic applications, is utilized in various medical fields, including neurology and aesthetic medicine.
In this context, the tender seeks qualified suppliers capable of providing high-quality botulinum toxin products that meet stringent pharmaceutical standards. Typical requirements for such procurements include the provision of detailed product specifications, including concentration, formulation, and storage conditions. Suppliers should also demonstrate their ability to supply the products consistently and reliably, ensuring timely delivery to healthcare facilities across the region.
Additionally, compliance with relevant regulatory frameworks, including licensing and certification for pharmaceutical distribution, is paramount. Suppliers may be required to present documentation that verifies the quality and safety of the products, including clinical trial results and post-marketing surveillance data.
As this tender is part of the public procurement process in Portugal, interested parties must register and submit their proposals through the BASE portal, which serves as a centralized platform for public contracts throughout mainland Portugal and its autonomous regions. This initiative not only aims to enhance the availability of essential medical supplies but also to promote transparency and competition within the pharmaceutical sector.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 12, 2026. Last refreshed 5 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Serviço de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM, EPERAM)
Serviço de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM, EPERAM) has issued 470 procurement notices on BidsFactory, including 4 currently open and 387 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Serviço de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM, EPERAM) in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €142,614. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.